Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kodiak Sciences Inc.

3.64
+0.19005.51%
Post-market: 3.640.00000.00%19:55 EDT
Volume:236.06K
Turnover:854.61K
Market Cap:191.11M
PE:-1.00
High:3.70
Open:3.50
Low:3.49
Close:3.45
Loading ...

KOD Completes Enrollment in Phase III Study for Eye Disease Candidate

Zacks
·
11 Mar

Kodiak Sciences completes enrollment in GLOW2 Phase 3 trial

TIPRANKS
·
11 Mar

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients With Diabetic Retinopathy

THOMSON REUTERS
·
11 Mar

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

PR Newswire
·
11 Mar

Kodiak Sciences granted orphan designation for tabirafusp alfa

TIPRANKS
·
05 Mar

We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate

Simply Wall St.
·
25 Feb

Canaccord Genuity Sticks to Their Buy Rating for Kodal Minerals (KOD)

TIPRANKS
·
12 Feb

Kodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025

PR Newswire
·
04 Feb

Here’s Why Kodiak Sciences Inc. (KOD) Is Skyrocketing

Insider Monkey
·
14 Jan

KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates

Zacks
·
06 Jan

Institutional investors have a lot riding on Kodiak Sciences Inc. (NASDAQ:KOD) with 43% ownership

Simply Wall St.
·
28 Dec 2024

What Awaits These 4 Biotech Stocks That More Than Doubled in 2024

Zacks
·
26 Dec 2024

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

Benzinga
·
23 Dec 2024

KOD Stock Up as Jefferies Upgrades Rating on Huge Pipeline Potential

Zacks
·
10 Dec 2024

Kodiak Sciences, Nona Biosciences partner on next-gen antibody therapies

TIPRANKS
·
10 Dec 2024

Sector Update: Health Care Stocks Edge Higher Monday Afternoon

MT Newswires Live
·
10 Dec 2024